Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
60.37
+0.01 (0.02%)
Sep 1, 2026, 1:32 PM EDT - Market open

Ionis Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
350.07372.26242.08399.27276.47869.19
Short-Term Investments
1,7522,3082,0611,9381,7211,264
Cash & Short-Term Investments
2,1022,6802,3032,3381,9972,133
Cash Growth
-8.31%16.39%-1.48%17.03%-6.37%12.32%
Receivables
58.8566.0692.1997.7825.5461.9
Inventory
50.8310.0512.517.4422.0324.81
Other Current Assets
279.24234.08212.67199.13157.72125.17
Total Current Assets
2,4912,9912,6202,6422,2032,345
Property, Plant & Equipment
386.69361.6256.11242.94255.84196.04
Long-Term Investments
19.8252.2141.0242.9940.3732.32
Other Long-Term Assets
96.72119.486.2662.2934.9738.28
Total Assets
2,9953,5243,0042,9902,5342,612

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
47.728.0842.9626.0317.9211.9
Accrued Expenses
166.07222.33178.05215.62189.28127.37
Current Portion of Long-Term Debt
12.92445.180.2245.070.320.9
Current Portion of Leases
-9.519.068.097.222.63
Current Income Taxes Payable
2.882.710.032.156.250.04
Current Unearned Revenue
73.8473.7678.99151.1390.5897.71
Total Current Liabilities
315.64781.57309.32448.09311.56240.55
Long-Term Debt
1,9141,8991,7881,7431,1831,228
Long-Term Leases
262.48262.38161.81170.88178.9419.43
Long-Term Unearned Revenue
63.0392156.5241.18287.77351.88
Total Liabilities
2,5553,0352,4152,6031,9611,840

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.170.160.160.140.140.14
Additional Paid-In Capital
3,3123,1452,8692,2152,0601,964
Retained Earnings
-2,838-2,631-2,250-1,796-1,430-1,160
Comprehensive Income & Other
-33.9-25.28-30.81-32.65-57.48-32.67
Total Common Equity
439.74489.09588.35386.69572.89771.74
Shareholders' Equity
439.74489.09588.35386.69572.89771.74
Total Liabilities & Equity
2,9953,5243,0042,9902,5342,612

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2,1892,6161,9591,9671,3691,251
Net Cash (Debt)
-86.6764.58344.14370.23628.21882.13
Net Cash Growth
--81.23%-7.05%-41.07%-28.78%-8.06%
Net Cash Per Share
-0.530.402.302.594.436.26
Filing Date Shares Outstanding
166.18165.19158.96145.75142.95141.69
Total Common Shares Outstanding
165.64163.3157.91144.34142.06141.21
Working Capital
2,1762,2092,3112,1941,8912,104
Book Value Per Share
2.652.993.732.684.035.47
Tangible Book Value
439.74489.09588.35386.69572.89771.74
Tangible Book Value Per Share
2.652.993.732.684.035.47
Land
--8.578.578.5723.06
Buildings
-41.841.2341.2341.16144.05
Machinery
-11.729.869.849.5810.59
Leasehold Improvements
-89.1554.3828.2828.3620.14
SEC Filings: 10-K · 10-Q